Please login to the form below

Not currently logged in
Email:
Password:

EASD 2013

This page shows the latest EASD 2013 news and features for those working in and with pharma, biotech and healthcare.

Novo backs Victoza's prospects in Alzheimer's

Novo backs Victoza's prospects in Alzheimer's

Speaking to PMLiVE at the European Association for the Study of Diabetes' (EASD) 2013 meeting in Barcelona last week, Novo's chief science officer Mads Krogsgaard Thomsen confirmed the drug, approved ... the end of 2013.

Latest news

More from news
Approximately 4 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics